Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2가정에서 채취한 혈액의 다중 분석물 혈청학은 SARS-CoV-2에 대한 면역 반응의 편견 없는 평가를 가능하게 합니다.Article Published on 2021-06-172022-09-12 Journal: Nature Communications [Category] MERS, SARS, 진단, [키워드] 95% CI accumulated antibody approach Asymptomatic biomedical engineering Blood collected consequence coronavirus COVID-19 pandemic develop Diagnostic markers Diversity dried blood spot Dried blood spots Epidemiology healthcare IgG IgG and IgM IgM immune response include individual Influenza influenza-like symptom Influenza-like symptoms Proteomic analysis random RBD S protein SARS-CoV-2 SARS-CoV-2 protein SARS-CoV-2 proteins Screen Serological testing serology seropositive Seroprevalence spring the S protein Viral proteins [DOI] 10.1038/s41467-021-23893-4 PMC 바로가기 [Article Type] Article
Longitudinal detection of SARS‐CoV‐2‐specific antibody responses with different serological methods다양한 혈청학적 방법을 통한 SARS-CoV-2 특이 항체 반응의 종단적 검출Comparative Study Published on 2021-06-112022-09-10 Journal: Journal of medical virology [Category] MERS, SARS, 진단, 치료기술, 치료법, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus analyzed antibodies antibody Antibody Response Antigen antigens assays Blood donors cells children collected Concentration coronavirus coronavirus disease Coronavirus disease 2019 COVID‐19 COVID‐19 detect diagnostic eight ELISA ELISAs healthy blood donors highest IgA IgG IgM immunofluorescence Immunoglobulin immunoglobulin A Immunoglobulin G immunoglobulin M immunosorbent indirect immunofluorescence individual infections information Kinetics longitudinal Patient peaked polymerase chain polymerase chain reaction Prevalence Protein provided respiratory S1 domain SARS‐CoV‐2 SARS‐CoV‐2‐infected SARS‐CoV‐2 seasonal coronaviruses selected sensitivities sensitivity sera serological serological assays Serological testing serology serum sample serum samples specific antibodies specific antibody specificity Spike protein substrate symptom onset tested the viral nucleocapsid Viral viral nucleocapsid protein virus [DOI] 10.1002/jmv.27113 PMC 바로가기 [Article Type] Comparative Study
Disease-dependent interaction policies to support health and economic outcomes during the COVID-19 epidemicArticle Published on 2021-06-102022-10-30 Journal: iScience [Category] COVID-19, [키워드] Abstract accelerated Analysis approach changes in COVID-19 COVID-19 epidemic develop disease status Efficiency feedback greater Health identify Impact improvement individual infection rate Interaction Isolation lockdown mitigate modulate outcome outcomes reduce risk Serological testing significantly lower Spread Support susceptible individual the epidemic Transmission Virology [DOI] 10.1016/j.isci.2021.102710 PMC 바로가기 [Article Type] Article
Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population3 개의 고 처리량 상업용 SARS-COV-2 항체 분석 간의 분석 비교Comparative Study Published on 2021-06-042022-09-01 Journal: Scientific Reports [Category] MERS, SARS, 진단, [키워드] 95% CI antibody assay Antibody testing assays automated Cohen’s kappa comparable discrepancy Elecsy Epidemiology Evidence evidence of individual individuals Infection infection rate infection rates Infectious diseases investigated PCR performance positive ranged reveal SARS-CoV-2 SARS-CoV-2 antibody serological Serological testing seropositive specimen viral infection was performed [DOI] 10.1038/s41598-021-91235-x PMC 바로가기 [Article Type] Comparative Study
Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations전염병에 대한 화학 예방 실험 설계: COVID-19 연구 등록에 대한 체계적인 검토에서 얻은 통찰력Review Published on 2021-05-292022-09-10 Journal: Trials [Category] SARS, 변종, 치료기술, 치료제, [키워드] adaptive adaptive design Adaptive platform trial Adults alignment Analysis attack rate attack rates Care Chain Reaction Chemoprophylaxis Chloroquine clinically collaboration component control group coronavirus country COVID-19 COVID-19 vaccines database detect effect size effective Efficacy Efficacy and safety eligibility enrolment Epidemic Epidemics epidemiologically Evidence evidence of exit feasible feature focus followed by General population generate healthcare worker Healthcare workers Hydroxychloroquine implementation Infection Infectious disease Infectious diseases information International IQR less Long-term care Lopinavir Lopinavir/ritonavir mechanism median median size novel vaccines offer Older older adult Older adults pandemic patients polymerase chain reaction Polymerase chain reaction testing PrEP Primary outcome Prophylaxis protocol provided public health randomised Rapid recruitment Registered Repurposed drug Repurposed drugs required Result review Ritonavir robust safety analysis SARS-CoV-2 screened searched Serological testing study population supplementary material Supporting systematic review target population Trial trial infrastructure Trial registration trials utility Vaccine Vaccines virus variants was used were assessed widespread without symptom [DOI] 10.1186/s13063-021-05323-4 PMC 바로가기 [Article Type] Review
Glycosylation is a key in SARS-CoV-2 infection당화는 SARS-CoV-2 감염의 핵심입니다Review Published on 2021-05-222022-09-12 Journal: Journal of Molecular Medicine (Berlin, Germany) [Category] MERS, SARS, 진단, [키워드] acting Adaptive immune response binding Blood group antigen cascade cause contribute COVID-19 cytokine disease epitope Epitopes Evidence Factor glycan glycans glycosylated glycosylation highlight host cell host cells IgG immune evasion Impact Infection innate and adaptive immune response monoclonal monoclonal antibody pandemic protective role Receptor-binding domain responsible S protein SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike glycoprotein SARS-CoV-2 spike protein Serological testing shown spike glycoprotein Spike protein subsequent syndrome target cell target cells the receptor-binding domain the SARS-CoV-2 Therapeutic strategies therapeutic strategy therapy vaccination Vaccines virus [DOI] 10.1007/s00109-021-02092-0 PMC 바로가기 [Article Type] Review
Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort studyObservational Study Published on 2021-05-202022-10-04 Journal: BMC Cancer [Category] SARS, 임상, [키워드] acute respiratory syndrome Admission Adult patient Adverse adverse event adverse events ambulatory anti-cancer treatment association Belgium bleeding event cancer patient cancer treatment cohort study Common Terminology Criteria Coronavirus-2 COVID-19 COVID-19 pandemic determine disease eligible patient hematological incidence Infection initial intensive care management MOST neutropenia Non-severe COVID-19 occurred Odds ratio oncology oncology patient outcome oxygen supplementation pandemic pandemic coronavirus Patient patients performance status positive remained reported required Result Risk factors RT-PCR Safe Safety SARS-CoV-2 SARS-CoV-2 RT-PCR test SARS-CoV-2-positive patient SARS-CoV-2-positive patients Serological testing serology severe COVID-19 single-center solid tumor supplementary material systemic systemic anti-cancer therapy Systemic anti-cancer treatment therapy treated Treatment [DOI] 10.1186/s12885-021-08349-8 PMC 바로가기 [Article Type] Observational Study
Development and Validation of a Multiplex Microsphere Immunoassay Using Dried Blood Spots for SARS-CoV-2 Seroprevalence: Application in First Responders in Colorado, USASARS-CoV-2 혈청 유병률에 대한 건조혈액 반점을 사용한 다중 미소구체 면역분석법의 개발 및 검증: 미국 콜로라도주 응급구조대에 적용Article Published on 2021-05-192022-09-11 Journal: Journal of Clinical Microbiology [Category] SARS, 진단, 치료법, [키워드] anti-N antibodies anti-N antibody anti-N IgG anti-RBD Anti-RBD IgG antibody Antibody Response Antibody responses Antibody testing application applied Blood correlated COVID-19 antibody COVID-19 antibody testing development dried blood spot testing ELISA enzyme enzyme immunoassay enzyme-linked immunosorbent enzyme-linked immunosorbent assay evaluated first responders fluorescence intensity geometric immunoassay Immunological Surveillance immunological surveillance. less median microsphere multiplex natural infection Neutralizing antibodies nucleocapsid Population predicted RBD RBD IgG Receptor binding domain Responder SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infection serological testing SARS-CoV-2 neutralizing antibodies SARS-CoV-2 neutralizing antibody serological Serological testing seropositive Seroprevalence serum spot the United State Transmission dynamics United States USA vaccination validation [DOI] 10.1128/JCM.00290-21 PMC 바로가기 [Article Type] Article
SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK: A retrospective cohort studyResearch Paper Published on 2021-05-182022-10-30 Journal: The Lancet Regional Health - Europe [Category] COVID-19, [키워드] 95% CI Action Adults affected age and sex all age group antibody titres Characteristics children Community COVID-19 COVID-19 symptoms cross-sectional declined disease Factor finding force of infection funding highest identify individuals Infection lockdown London lowest MRC Multiplex assay National NIHR nucleocapsid pandemic Participants performed Population questionnaire random-effects model recruited reduce reported required retrospective cohort study SARS-CoV-2 SARS-CoV-2 IgG antibodies SARS-CoV-2 seroprevalence Serological testing Serosurvey Socioeconomic deprivation stratified symptomatic individual titre titres Transmission Wellcome Trust [DOI] 10.1016/j.lanepe.2021.100127 PMC 바로가기 [Article Type] Research Paper
Dynamics of anti-SARS-CoV-2 IgG antibodies post-COVID-19 in a Brazilian Amazon population브라질 아마존 인구에서 COVID-19 이후 항 SARS-CoV-2 IgG 항체의 역학Observational Study Published on 2021-05-152022-09-01 Journal: BMC Infectious Diseases [Category] SARS, 임상, 진단, 치료기술, [키워드] (coronavirus disease 2019 Amazon anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG anti-SARS-CoV-2 IgG antibodies anti-SARS-CoV-2 IgG antibody antibody blood sample both sexes Characteristics clinical conditions coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 diagnosis detectable diagnosed with COVID-19 Diagnosis disease severity Dynamics epidemiological evaluated first test first visit Frequency Hospital stay IgG IgG antibodies IgG antibody IgG response individual Laboratory Longevity manifestation Older oxygen persistence Prevalence reactivity recruited reported symptom respiratory Result SARS-CoV-2 selected serological profile serological test Serological testing Severe acute respiratory syndrome severity supplemental oxygen Symptom Symptoms Volunteer volunteers [DOI] 10.1186/s12879-021-06156-x PMC 바로가기 [Article Type] Observational Study